Bridgeway Capital Management, LLC Amneal Pharmaceuticals, Inc. Transaction History

Bridgeway Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$3.95 - $5.85 $328,640 - $486,719	-83,200 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$5.12 - $6.82 $63,488 - $84,568	-12,400 Reduced 12.97%	83,200 $426,000
Q1 2021 May 17, 2021	SELL	$4.74 - $7.38 $885,432 - $1.38 Million	-186,800 Reduced 66.15%	95,600 $643,000
Q4 2020 Feb 16, 2021	BUY	$3.95 - $5.42 $72,680 - $99,728	18,400 Added 6.97%	282,400 $1.29 Million
Q3 2020 Nov 16, 2020	BUY	$3.54 - $5.27 $65,490 - $97,494	18,500 Added 7.54%	264,000 $1.02 Million
Q2 2020 Aug 14, 2020	BUY	$2.87 - $5.46 $704,585 - $1.34 Million	245,500 New	245,500 $1.17 Million

184

141M

57K

49K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.19B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.